especialidad

Biblioteca Posters Congresos – 2026 – eado – praga

biblioteca-posters-congresos-banner-sin-fondo

Evidencia reciente en congresos

A continuación, podrás acceder a los datos más recientes, presentados en los últimos congresos sobre el tratamiento de la psoriasis, la queratosis actínica leve en adultos e infecciones fúngicas leves o moderadas de las uñas:

2026
2025
2024
banner landing 2026 eado praga
Sequential keratolytic pretreatment enhances tirbanibulin efficacy in field cancerization assessed by line-field confocal optical coherence tomography: a pilot studv
VISUALIZAR
Pigmented Actinic Keratoses on the Face: Dermoscopic Features and Therapeutic response to Tirbanibulin - A Biopsy-confirmed Case Series
VISUALIZAR
box 3 2026 eado praga
VISUALIZAR
Sustained real-world effectiveness of tirbanibulin1% for actinic keratoses in solid organ transplant recipients
VISUALIZAR
Real-World Experience with Tirbanibulin 1% in Actinic Keratosis: Does Polypharmacy Influence Therapeutic Outcomes?
VISUALIZAR
Efficacy and safety of tirbanibulin 1% ointment in elderly patients with actinic keratosis: a pooled analysis of Phase 3 clinical trials
VISUALIZAR
Dermatología
.
Otras especialidades
Otros contenidos
©2026 Almirall
©2026 Almirall

EADO- 2026 – Praga

Sequential keratolytic pretreatment enhances tirbanibulin efficacy in field cancerization assessed by line-field confocal optical coherence tomography: a pilot studv

EADO – 2026 – Praga

Pigmented Actinic Keratoses on the Face: Dermoscopic Features and Therapeutic response to Tirbanibulin - A Biopsy-confirmed Case Series

EADO – 2026 – Praga

Sustained real-world effectiveness of tirbanibulin1% for actinic keratoses in solid organ transplant recipients

EADO – 2026 – Praga

Sustained real-world effectiveness of tirbanibulin1% for actinic keratoses in solid organ transplant recipients

EADO – 2026 – Praga

Real-World Experience with Tirbanibulin 1% in Actinic Keratosis: Does Polypharmacy Influence Therapeutic Outcomes?

EADO – 2026 – Praga

Efficacy and safety of tirbanibulin 1% ointment in elderly patients with actinic keratosis: a pooled analysis of Phase 3 clinical trials

La información proporcionada en este sitio web está destinada a profesionales de la salud capacitados para prescribir y suministrar medicamentos, así que requieren conocimiento científico específico y formación para interpretarla correctamente.

Soy profesional de la salud